Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.
Mohan M, Szabo A, Patwari A, Esselmann J, Patel T, Bachu R, Rein LE, Janardan A, Bhatlapenumarthi V, Annyapu E, Skoog C, Goff A, Hadidi SA, Radhakrishnan SV, Thanendrarajan S, Zangari M, Shah N, van Rhee F, Dhakal B, Hamadani M, D'Souza A, Schinke C.
Mohan M, et al. Among authors: patel t.
Bone Marrow Transplant. 2024 Feb 15. doi: 10.1038/s41409-024-02233-2. Online ahead of print.
Bone Marrow Transplant. 2024.
PMID: 38361116